Cost‐effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment‐naïve adults with<scp>HIV</scp>‐1 infection in the<scp>UK</scp>, based on the<scp>AIDS</scp>Clinical Trials Group 5202 clinical trial
Ed Wilkins(North Manchester General Hospital), Elizabeth M. La(RTI Health Solutions)
Cited by 7
Related Papers
No related papers found
Powered by citation graph analysis